Double liposomes: Hypoglycemic effects of liposomal insulin on normal rats

Drug Development and Industrial Pharmacy

Volumn 29, Issue 7, 2003, Pages 725-731

  Katayama, Ken ^a   Kato, Yoshinori ^a   Onishi, Hiraku ^a   Nagai, Tsuneji ^a   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Double liposomes; Glassfilter method; Hypoglycemic effects; Insulin; Oral administration; Protease inhibitor

Indexed keywords

APROTININ; CALCEIN; DOUBLE LIPOSOME; INSULIN; LIPOSOME; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUSTRY; ENCAPSULATION; ENZYMATIC DEGRADATION; ENZYME DEGRADATION; HYPOGLYCEMIA; INSULIN TREATMENT; LIPID ANALYSIS; MALE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DEGRADATION; RAT; SURFACE CHARGE; SURFACE PROPERTY;

ANIMALS; APROTININ; BIOPHARMACEUTICS; DOSAGE FORMS; DRUG STABILITY; HYPOGLYCEMIA; INSULIN; INTUBATION, GASTROINTESTINAL; LIPOSOMES; MALE; RATS; RATS, WISTAR; TECHNOLOGY, PHARMACEUTICAL;

EID: 0038301700     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120021771     Document Type: Article

References (18)

1. Morishita, M.; Morishita, I.; Takayama, K.; Machida, Y.; Nagai, T. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int. J. Pharm. 1992, 78, 1-7.
2. Morishita, I.; Morishita, M.; Takayama, K.; Machida, Y.; Nagai, T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm. 1992, 78, 9-16.
3. Takahashi, Y.; Iwata, M. Recent trial for hypoglycemic preparations. Pharm. Tech. Japan 2000, 16, 1633-1637.
4. Ostro, M.J. Liposomes. Sci. Am. 1987, 256, 90-99.
5. Kikuchi, H.; Inoue, K. Liposomes: properties and applications. Yukagaku 1985, 34, 784-798.
6. Dusserre, N.; Lessard, C.; Paquette, N.; Perron, S.; Poulin, L.; Tremblay, M.; Beauchamp, D.; Désormeaux, A.; Bergeron, M.G. Encapsulation of foscarnet in liposomes modifies drug intracellar accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS 1995, 9, 833-841.
7. Van Slooten, M.L.; Storm, G.; Zoephel, A.; Kupcu, Z.; Boerman, O.; Crommelin, D.J.A.; Wagner, E.; Kircheis, R. Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm. Res. 2000, 17, 42-48.
8. Hwang, S.H.; Hayashi, K.; Takayama, K.; Maitani, Y. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes. Gene Ther. 2001, 8, 1276-1280.
9. Liu, F.; Huang, L. Development of non-viral vectors for systemic gene delivery. J. Contr. Release 2002, 78, 259-266.
10. Katayama, K.; Kato, Y.; Onishi, H.; Nagai, T.; Machida, Y. Preparation of novel double liposomes using the glass-filter method. Int. J. Pharm. 2002, 248, 93-99.
11. Kim, S.; Turker, M.S.; Chi, E.Y.; Sela, S.; Martin, G.M. Preparation of multivesicular liposomes. Biochim. Biophys. Acta 1983, 728, 339-348.
12. Talsma, H.; Jousma, H.; Nicolay, K.; Crommelin, D.J.A. Multilamellar or multivesicular vesicles? Int. J. Pharm. 1987, 37, 171-173.
13. Walker, S.A.; Kennedy, M.T.; Zasadzinski, J.A. Encapsulation of bilayer vesicles by self-assembly. Nature 1997, 387, 61-64.
14. Nakazawa, H.; Nagase, M. Reversed-phase high-performance liquid chromatography of peptides. Yakugaku Zasshi 1986, 106, 398-405.
15. Shew, R.L.; Deamer, D.W. A novel method for encapsulation of macromolecules in liposomes. Biochim. Biophys. Acta 1985, 816, 1-8.
16. Weingarten, C.; Moufti, A.; Delattre, J.; Puisieux, F.; Couvreur, P. Protection of insulin from enzymatic degradation by its association to liposomes. Int. J. Pharm. 1985, 26, 251-257.
17. Patel, H.M.; Stevenson, R.W.; Parsons, J.A.; Ryman, B.E. Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs. Biochim. Biophys. Acta 1982, 716, 188-193.
18. Yamabe, K.; Kato, Y.; Onishi, H.; Machida, Y. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J. Control. Rel. 2003, 89, 429-436.